CYP2C8 rs1058930: Understanding Your Genetic Variant

What each genotype means

What is rs1058930?

The rs1058930 variant is a single nucleotide polymorphism (SNP) situated in the CYP2C8 gene. In genetic literature, this specific variant is frequently referred to as the CYP2C8*4 allele. A SNP represents a variation at a single position in the DNA sequence among individuals. Because this variant is located within a gene that provides instructions for making a protein, researchers study it to determine if the change in the DNA code alters the function or efficiency of the resulting enzyme. Located on chromosome 10, the CYP2C8 gene is part of the cytochrome P450 superfamily, a group of enzymes primarily involved in the metabolism of xenobiotics, which include drugs, toxins, and other foreign substances. By studying where this SNP sits, scientists can better understand how genetic diversity contributes to the variability in how different people process medications.

The Role of the CYP2C8 Gene

The CYP2C8 gene encodes the cytochrome P450 2C8 enzyme, which is predominantly expressed in the liver. This enzyme plays a critical role in the phase I metabolism of a wide array of therapeutic drugs, including certain anti-inflammatory medications, antidiabetics, and chemotherapy agents. By chemically modifying these substances, the enzyme helps the body prepare them for excretion. When a genetic variant like rs1058930 is present, it may lead to a change in the amino acid sequence of the enzyme, potentially resulting in reduced metabolic activity. This is why the variant is often studied in the context of pharmacogenomics—the field that examines how an individual's genetic makeup influences their response to drugs. Understanding the function of this gene is essential for researchers who aim to predict how different genotypes might affect the clearance rates of specific medications in the bloodstream.

Research and Evidence Strength

The association between rs1058930 and clinical outcomes is considered to have limited evidence strength. Some studies have explored whether this variant influences the lymph node status of breast cancer patients or affects the metabolism of chemotherapy agents. However, findings in this area are often mixed, and it is difficult to isolate the effect of a single SNP from other genetic and environmental factors. For instance, some research has noted that the impact of this variant might be influenced by linkage disequilibrium, where it is inherited alongside other nearby variants, such as those in the CYP2C9 gene. Because the evidence is not definitive, it is not currently used as a standard clinical tool for predicting cancer risk or guiding treatment. Large-scale, independent studies are still required to confirm whether this variant has a consistent, measurable impact on health outcomes across diverse populations.

Population Frequency

The rs1058930 variant is considered to have a moderate frequency across various global populations. Genetic databases indicate that the prevalence of the variant allele can vary significantly depending on ancestral background. Because frequency data is derived from large-scale sequencing projects, it provides a snapshot of how common this genetic change is in the general population. It is important to note that having a common variant does not necessarily imply a specific health outcome, as most common SNPs have small or negligible effects on overall health. Researchers use these frequency data to ensure that genetic studies are representative of diverse groups, which helps in understanding whether associations found in one population hold true for others. If you are interested in your own genetic profile, population frequency data can provide context, but it should not be used to infer personal health risks.

What You Can Do With This Information

Information about your genotype for rs1058930 is primarily educational and should not be used to make medical decisions. Because the evidence linking this variant to specific health outcomes is limited and not currently used in routine clinical practice, it does not provide a clear roadmap for diagnosis or treatment. If you have concerns about how your body processes medications, or if you are undergoing treatment for a condition like breast cancer, the most important step is to have an open conversation with your healthcare provider or a clinical pharmacist. They can review your medical history, current medications, and clinical needs to provide personalized guidance. Never change your medication dosage or treatment plan based on genetic test results without consulting a professional. Genetic information is just one piece of a much larger puzzle that includes your lifestyle, environment, and overall health status.

Frequently asked questions

Sources & further reading